Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has awarded two new research grants to support studies on zipalertinib, a promising therapy for Non-Small ...